Vascular Biogenics (NASDAQ:VBLT) Research Coverage Started at StockNews.com

Analysts at StockNews.com started coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Get Rating) in a note issued to investors on Monday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Vascular Biogenics Stock Performance Vascular Biogenics stock opened at $0.13 on Monday. Vascular Biogenics has a 52 week low of $0.11 and […]